Potential therapeutic target for deadly form of childhood leukaemia found
December 15th, 2009 - 5:04 pm ICT by ANILondon, Dec 15 (ANI): Scientists from Loyola University Chicago Stritch School of Medicine and the University of Virginia have found a gene that can act as a potential therapeutic target for deadly form of childhood leukemia called mixed-lineage leukemia (MLL).
MLL is caused by a critical gene that regulates hundreds of other genes in blood cells. The problem occurs when this regulatory gene breaks in half and another gene attaches to it, creating a fusion gene. It’s this fusion gene that turns a normal cell into a proliferating cancer cell.
“This hopefully will lead to an effective therapeutic approach for patients who generally do not do well with current treatments,” said second senior author Dr Nancy Zeleznik-Le, a professor in the Department of Medicine at Loyola Stritch.
A drug might help disable the protein that turns normal blood cells into cancer cells.
This fusion gene codes for a MLL fusion protein. The MLL fusion protein in turn binds to hundreds of other genes.
Consequently, these genes are permanently turned on. So instead of aging and dying like a normal cell, the cell turns cancerous, continually growing and dividing into new cancer cells.
Zeleznik-Le said researchers are likely to get ready to test potential drug compounds on laboratory animals within a year.
The study appears in journal Nature Structural and Molecular Biology. (ANI)
- Bioengineered protein may help fight leukemia - Feb 19, 2011
- New gene findings may help treat infant leukemia - Dec 06, 2009
- New research could help open ways to shrink skin cancers - Jan 18, 2010
- Factor boosting leukemia's aggressiveness identified - Oct 23, 2010
- Genome code for most common form of pediatric brain cancer cracked - Dec 17, 2010
- One in 25 Indians carries gene that triggers heart failure - Jun 10, 2010
- First molecule that blocks key component of cancer genes' on-off switch created - Sep 25, 2010
- Small molecule may deactivate enemy of cancer-fighting p53 - Dec 08, 2010
- Mouse genome offers human cancer clue - Mar 24, 2011
- Antibiotic paves way for novel anti-cancer agents - Jan 29, 2011
- Drug for rare childhood cancer may help prevent prostate cancer spread - Apr 30, 2011
- New study shows evidence of stem cells' pivotal role in cancer - Dec 22, 2010
- How genetic changes make some brain cancers more aggressive - Oct 02, 2010
- Key pathway implicated in progression of childhood cancer found - Sep 19, 2010
- How skin cells turn cancerous in sunlight - Jan 16, 2010
Tags: blood cells, cancer cell, cancer cells, chicago stritch school, childhood leukaemia, childhood leukemia, critical gene, drug compounds, fusion gene, fusion protein, laboratory animals, loyola stritch, loyola university chicago, nature structural and molecular biology, regulatory gene, stritch school of medicine, therapeutic approach, therapeutic target, university chicago stritch school, zeleznik